TECON BIOLOGY CO.LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.75 CNY | 0.00% |
|
+5.80% | -23.03% |
| 04-10 | Tecon Biology's Pig Sales Revenue Climbs 12% in March | MT |
| 04-08 | Tiankang Biotechnology's Chairman Retires | MT |
| Sales 2023 * | 18.06B 2.49B 200B | Sales 2024 * | 21.11B 2.91B 233B | Capitalization | 9.22B 1.27B 102B |
|---|---|---|---|---|---|
| Net income 2023 * | -735M -101M -8.12B | Net income 2024 * | 765M 106M 8.45B | EV / Sales 2023 * | 0.76 x |
| Net Debt 2023 * | 4.43B 612M 48.97B | Net Debt 2024 * | 4.36B 602M 48.23B | EV / Sales 2024 * | 0.64 x |
| P/E ratio 2023 * |
-12.5
x | P/E ratio 2024 * |
12
x | Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
0.98% | Free-Float | 65.06% |
More Fundamentals
* Assessed data
More news
| 1 week | +5.80% | ||
| Current month | -11.76% | ||
| 1 month | -9.64% | ||
| 3 months | -13.13% | ||
| 6 months | -5.20% | ||
| Current year | -23.03% |
1 week
6.30
6.97
1 month
6.307.87
Current year
6.159.08
1 year
6.159.08
3 years
6.1513.20
5 years
6.1519.70
10 years
3.6519.70
| Managers | Title | Age | Since |
|---|---|---|---|
Hui Cheng
CEO | Chief Executive Officer | 59 | 19/12/03 |
Li Xin Geng
DFI | Director of Finance/CFO | 57 | 20/01/10 |
Yun Jiang Guo
BRD | Director/Board Member | 54 | 12/03/07 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yan Yang
CHM | Chairman | 62 | 19/12/03 |
Hui Cheng
CEO | Chief Executive Officer | 59 | 19/12/03 |
Li Xin Geng
DFI | Director of Finance/CFO | 57 | 20/01/10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 6.75 | 0.00% | 14,479,440 |
| 25/04/24 | 6.75 | +0.45% | 8,539,733 |
| 24/04/24 | 6.72 | -1.61% | 14,872,790 |
| 23/04/24 | 6.83 | +0.15% | 19,270,270 |
| 22/04/24 | 6.82 | +6.90% | 33,675,940 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
XINJIANG TECON ANIMAL HUSBANDRY BIO-TECHNOLOGY Co., LTD. is a China-based company, principally engaged in the production and distribution of feeds and related products. The Company's main businesses and products include premium incomes, slaughter processing and distribution of meat products, pig farming, production and distribution of feeds and veterinary drugs, and agricultural products processing. The Company mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.
Sector
Food Processing
Calendar
28/04/2024
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
6.75
CNY
Average target price
8.8
CNY
Spread / Average Target
+30.37%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.03% | 1.27B | |
| -4.93% | 266B | |
| -2.51% | 94.98B | |
| +3.19% | 46.39B | |
| +8.74% | 39.99B | |
| -0.65% | 39.95B | |
| -0.15% | 38.02B | |
| -16.78% | 30.16B | |
| -6.61% | 28.72B | |
| +11.32% | 24.54B |
- Stock Market
- Equities
- 002100 Stock
